BioSpace News Archive

Lyell Immunopharma, Inc. announced that members of its senior management team will participate in the following upcoming healthcare conferences:

Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the Wells Fargo 2023 Healthcare Conference to be held September 6-8, 2023.

Centogene N.V. announced that it has received a written notification from the Nasdaq Stock Market LLC dated August 30, 2023, indicating that the Company is not in compliance with the minimum Market Value of Publicly Held Shares set forth in the Nasdaq Rules for continued listing on the Nasdaq Global Market.

Adicet Bio, Inc., a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, announced it granted inducement awards on August 31, 2023.

Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, today announced its participation in two upcoming investment conferences.

Avid Bioservices, Inc. (NASDAQ:CDMO) today announced that it will report financial results for the first quarter of fiscal year 2024 on September 7, 2023, after market close and will host a webcast at 1:30 PM Pacific Time (4:30 PM Eastern Time).

MacroGenics, Inc., a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, announced that the Company’s management will participate in the following upcoming investor conferences.

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”) is pleased to announce that Harvest Medicine’s study entitled, “Self-Reported Effects of Illness Severity, Depression and Anxiety in Fibromyalgia Patients: A Large Retrospective Case Series” has been published in the peer-reviewed American Journal of Endocannabinoid Medicine.

BioCare, Inc., a leading specialty pharmaceutical distribution partner known for its specialty distribution and logistics services, has once again secured a place on the Inc. 5000 list of fastest-growing private companies in America.

UroGen Pharma Ltd. announced that it will present at the following investor conferences in September.